Nrxpharma
Wilmington, US · Founded 2017 · 1 known investors
NRx Pharmaceuticals develops medicines for people with unmet medical needs, focused on making untreatable diseases treatable. It operates in the pharmaceutical and biotech industry.
Founders & leadership
Nrxpharma was founded in 2017 by Jonathan Javitt, Jonathan C. Javitt, and Daniel C. Javitt.
JJ
Jonathan JavittFounder, Chairman & CEO
JC
Jonathan C. JavittFounder, Chairman & Chief Scientist; Co-CEO HOPE Therapeutics
DC
Daniel C. JavittCo-founder & Chair, Scientific Advisory Board
MA
Michael AbramsChief Financial Officer
KB
Kim BennettChief Investment Officer
RA
Richard AckermanChairman, President and Chief Executive Officer
LB
Lori B. WittmanChief Financial Officer and Director
RP
Rick PanicucciChief Manufacturing Officer
DK
Dennis K. McBrideChief Strategy Officer
GD
Glenn D. TysonChief Commercial Officer
JB
Joshua BrownChief Medical Innovation Officer
MF
Michael FongNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$6M disclosed across 2 rounds · 2017–2025
▶$3.5MraisedMar 2025 · 2 investors · BiotechnologyRule 506(b)
▶$3.5MraisedMar 2025 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Patrick FlynnDirector
- Michael AbramsExecutive Officer
- Michael TaylorDirector
- Jonathan JavittExecutive Officer, Director
- Chaim HurvitzDirector
- Dennis McBrideDirector
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- Sales commissions
- $245K
- Placement agents
- D. Boral Capital
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedNov 2017 · 1 investors · CommercialRule 506(b)
▶$2.5MraisedNov 2017 · 1 investors · Commercial
Rule 506(b)Officers, directors & promoters on the filing
- Kim BennettExecutive Officer
- Michael FongDirector
- Richard AckermanExecutive Officer, Director
- Lori B. WittmanExecutive Officer, Director
- Troy T. TaylorDirector
- Stuart F. KoenigDirector
- Albert G. RexDirector
- Richard BardoffDirector
- Offering amount
- $2.8M
- Amount sold
- $2.5M
- Minimum investment
- $25K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Seeking Alpha33 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Robinhood32 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Companies competing with Nrxpharma for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Nrxpharma do?
- NRx Pharmaceuticals develops medicines for people with unmet medical needs, focused on making untreatable diseases treatable. It operates in the pharmaceutical and biotech industry.
- Who founded Nrxpharma?
- Nrxpharma was founded by Jonathan Javitt, Jonathan C. Javitt, Daniel C. Javitt in 2017.
- Who are Nrxpharma's investors?
- Nrxpharma's investors include Kinled Holding.
- How much funding has Nrxpharma raised?
- Nrxpharma has disclosed $6M raised across 2 rounds.
- Where is Nrxpharma headquartered?
- Nrxpharma is headquartered in Wilmington, US.